AVITA Medical, Inc.
RCEL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.5% | 0.6% | -5.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 81.2% | 84.7% | 87.6% | 83.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -44% | -65.3% | -53.6% | -74.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -53.9% | -74.9% | -63% | -82.9% |
| EPS Diluted | -0.38 | -0.53 | -0.44 | -0.62 |
| % Growth | 28.3% | -20.5% | 29% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |